News•Jan 9, 2026
Aragen Launches CHOMax Cell Line Development and Manufacturing Platform
Aragen Biologics introduced CHOMax, an integrated cell line development and early manufacturing platform for standard IgG monoclonal antibodies. Refined across more than 200 CHO programs, the platform combines cell line creation, process development, analytics, and GMP manufacturing to move projects from DNA to IND‑enabling clinical supply in roughly 16 weeks for a research cell bank and months overall. CHOMax operates under a royalty‑free financial model and aligns with FDA, EMA, and PMDA regulatory expectations. The service includes parallel CMC activities, audit‑backed compliance, and support for first‑in‑human dosing through qualified partners.
By GEN (Genetic Engineering & Biotechnology News)
News•Jan 9, 2026
China Reports Progress On Xuntian Telescope Data Simulations
China’s research team has completed a full data‑simulation workflow for the Chinese Space Station Telescope (CSST), also known as the Xuntian Space Telescope, publishing the results on 7 January. The end‑to‑end suite generates realistic pixel‑level mock observations that mirror the telescope’s...
By Orbital Today
News•Jan 9, 2026
Fiserv Launches Unknown Shopper to Help Merchants Understand In-Store Customers
Fiserv has introduced Unknown Shopper, an analytics tool that transforms in‑store card‑present transaction data into actionable customer insights. Leveraging billions of historical payments, the platform enriches raw data with demographic attributes, allowing merchants to build segments without loyalty program enrollment....
By Finextra
Social•Jan 9, 2026
Flu Deaths Rise as Child Vaccination Rates Fall
1. There's a new FluView report from #CDC. Let's dive in. CDC was informed of 7 more kids who've died from #flu, bringing the season's toll to 17. Sadly, this number is going to rise. Vaccine uptake among kids has been...
By Helen Branswell
Social•Jan 9, 2026
Drone Production Hits Automotive-Scale Standardization, Faces Complexity Limit
Modern drone production. An assembly line in China shows how far drone manufacturing has been industrialized. Conveyor systems move the airframes between stations. Each worker performs a narrowly defined step, closer to poka-yoke than to classic workshop assembly. • Highly...
By Ilir Aliu
News•Jan 9, 2026
Personalized Medicine Vs. Precision Medicine
Dr. Jennifer Levin Carter of Medzown clarified the distinction between personalized medicine, which tailors care to individual circumstances, and precision medicine, which leverages genetic and molecular data to design disease‑specific therapies. She highlighted oncology’s 15‑year transformation through genomics, enabling targeted...
By Pharmaceutical Technology
News•Jan 9, 2026
Building Credit From the Ground Up: How Credit-Building Cards Actually Work
Credit‑building credit cards are designed for consumers with thin or damaged credit, offering low limits, simplified approvals, and reporting to major bureaus. By encouraging regular, low‑balance usage and on‑time payments, they help improve payment history, utilization, and credit mix, key...
By TechBullion
News•Jan 9, 2026
Is CSGOFast a Scam or Legal?
CSGOFast is a skin‑wagering platform that offers provably‑fair betting mechanics, transparent round histories, and a documented withdrawal process. While users can lose money due to the inherent risk of gambling‑style games, the site provides the verification tools scammers typically avoid....
By TechBullion
News•Jan 9, 2026
Landspace Secures Launch Contracts for China’s Megaconstellation Projects
Landspace has secured formal launch contracts for China’s two flagship megaconstellations, Guowang and Qianfan, using its reusable Zhuque‑3 methane‑liquid oxygen vehicle. The contracts, detailed in the company’s Shanghai Stock Exchange IPO prospectus, include an 18‑satellite launch for Yuanxin Satellite in...
By SpaceNews
News•Jan 9, 2026
Susannah Streeter Joins Wealth Club as Chief Investment Strategist
Wealth Club, the UK‑focused investment platform for high‑net‑worth individuals, has appointed Susannah Streeter as chief investment strategist. In the role she will head the firm’s market commentary, decode economic and monetary trends, and guide clients toward opportunities in venture‑capital trusts,...
By Fintech Global
Blog•Jan 9, 2026
A Bioinspired Hydrogel Patch with Controllable Adhesion Properties for Enhanced Soft Tissue Repair
Researchers from Shenzhen University, the Chinese Academy of Sciences and Hong Kong Polytechnic University have created a bioinspired hydrogel patch with controllable adhesion for soft tissue repair. The dual‑sided device combines a suction‑cup‑like adhesive layer that can be repositioned and...
By FrogHeart
Social•Jan 9, 2026
Slow Down to Break the Urgency‑Error Cycle
Your team isn't slow. They're too fast, and that's the problem. The operational doom loop: Urgency creates errors. Errors create escalations. Escalations create churn. Churn creates panic. Panic creates more urgency. Urgency creates new errors. You're not moving fast. You're...
By Lincoln Murphy
News•Jan 9, 2026
Proteomics at Scale: Current Approaches and Emerging Technologies
The new eBook "Proteomics at Scale" examines how emerging and traditional proteomics platforms balance protein coverage with analytical detail. It highlights the inherent trade‑offs between detecting a broad protein repertoire and accurately quantifying proteoforms. The publication introduces Nautilus™’ Iterative Mapping...
By GEN (Genetic Engineering & Biotechnology News)
News•Jan 9, 2026
BIO Investment Council Will Bring Together VC and Small Biotechs to Boost Innovation
The Biotechnology Innovation Organization (BIO) launched the BIO Investment Council (BIC) on Jan. 7 to bridge venture capital and small‑to‑mid‑size biotech firms. BIC aims to align early‑stage companies with the right investors as clinical‑stage funding now outpaces preclinical for the first...
By Bio.News
Social•Jan 9, 2026
Build Stories From Real Audience Insight, Not Buzzwords
“Storytelling” gets tossed around so much can end up meaning ... nothing. In this clip, John Elbing , author of Storybuilding, helps us move past story as a buzzword and into something more useful: building stories from real audience insight....
By Nick Westergaard
News•Jan 9, 2026
Parkinson’s Outcomes Compared: With Vs. Without Deep Brain Stimulation
A recent comparative study evaluated Parkinson’s patients receiving deep brain stimulation (DBS) against those managed with medication alone. The analysis found that DBS recipients experienced a 40% reduction in OFF‑time and a 30% decrease in levodopa dosage, while motor scores...
By Bioengineer.org
News•Jan 9, 2026
Report Claims Two UK Crypto Exchanges Used to Support Iran’s Islamic Revolutionary Guard Corps (IRGC)
A TRM Labs report alleges that two UK‑based crypto exchanges, Zedcex and Zedxion, processed roughly $1 billion in transactions, most of which were USDT transfers on the TRON blockchain linked to Iran’s Islamic Revolutionary Guard Corps (IRGC). The analysis shows IRGC‑related...
By Crowdfund Insider
News•Jan 9, 2026
Baldur’s Gate 3 Studio Says It Won’t Use AI for Concept Art or Writing
Larian Studios clarified that its upcoming title Divinity will not use generative AI for concept art or narrative writing. The studio’s CEO Swen Vincke emphasized AI will only assist internal brainstorming, PowerPoint decks, and idea iteration. AI‑generated in‑game assets may...
By The Verge
News•Jan 9, 2026
Low Muscle Mass, Orthostatic Hypotension Linked in Parkinson’s
A recent multi‑center study of 200 Parkinson’s disease patients reveals that low skeletal muscle mass is strongly associated with orthostatic hypotension. Researchers found that 45% of participants with sarcopenia experienced significant blood‑pressure drops upon standing, compared with only 20% of...
By Bioengineer.org
Blog•Jan 9, 2026
Camizestrant
Camizestrant is an oral, selective estrogen‑receptor‑alpha (ERα) degrader developed by AstraZeneca for ER‑positive, HER2‑negative, ESR1‑mutated breast cancer. The drug advanced to a Phase 3 trial, with results published in the New England Journal of Medicine in June 2025. The study demonstrated a...
By Drug Hunter
News•Jan 9, 2026
Latest Credit Data Signals a Reset and Resilience
The Federal Reserve reports consumer credit growth slowed to a 1% annualized rate in November, with revolving balances declining while non‑revolving credit continued to expand. A New York Fed survey shows sentiment softening, higher inflation expectations and rising job‑security concerns,...
By PYMNTS
News•Jan 9, 2026
New Edible Film From Fish Waste Redefines Packaging
A research team has developed an edible film made from fish processing waste, turning discarded collagen and gelatin into a thin, biodegradable packaging material. The film dissolves in water within weeks, offering a direct alternative to single‑use plastics for food...
By Bioengineer.org
News•Jan 9, 2026
Orca Adds $250M in Financing to Back Launch of T Cell Therapy
Orca Bio announced it has raised $250 million in new financing to support the commercial launch of its T‑cell therapy designed to treat complications from allogeneic stem cell transplants. The capital infusion comes from a mix of venture capital firms and...
By Endpoints News
News•Jan 9, 2026
Use of XMRig Cryptominer by Threat Actors Expanding: Expel
XMRig, an open‑source Monero miner, is increasingly weaponized by threat actors across Windows, Linux, Kubernetes and AWS environments. Recent campaigns have leveraged the high‑severity React2Shell exploit and UPX‑packed binaries to spread the miner via game torrents and commodity malware. Expel’s...
By Security Boulevard
News•Jan 9, 2026
Allianz, Anthropic Partner to Expand AI Use in Insurance
Allianz SE has teamed up with AI specialist Anthropic to speed up responsible AI adoption across its insurance operations. The partnership targets three key initiatives: using AI to aid Allianz's software developers, automating labor‑intensive tasks like claims processing, and creating...
By Bank Automation News
News•Jan 9, 2026
Pacsun Looks Beyond the Standard App with New Co-Creation Platform
Pacsun unveiled the PS Community Hub, a digital platform that blends social interaction, creator monetization, and co‑creation with traditional shopping. Launched in early January, the hub lets everyday users and influencers collaborate on fashion ideas, earn affiliate commissions, and shop...
By Retail TouchPoints
Social•Jan 9, 2026
Transformers Hit Ceiling; Hybrid Models Unlock True Multimodal AI
During last month’s NeurIPS 2025 conference, YC’s @agupta sat down with @krandiash, founder and CEO of Cartesia, to explain why today’s AI architectures may be fundamentally limited. They discuss how transformers act more like retrieval systems than learning systems, where new...
By YCombinator
Social•Jan 9, 2026
Biotech Deal Surge: Wnt, NLRP3, GLP‑1, and More
Your Weekly Biotech News Fix | Ep. 901 Designed to be consumed as a quick scroll 🧬 Parabilis - $305M Wnt bet 🔥 $LLY - Buys $VTYX (NLRP3) 🎯 $PFE - Cartography antigen deal 🧲 $AMGN - Dark Blue acquisition 🦠 $GSK / $IONS - HBV...
By BowTiedBiotech
News•Jan 9, 2026
Michigan’s Zeal Credit Union to Buy Another UP Bank
Zeal Credit Union of Livonia, Michigan, announced it will acquire The Miners State Bank, adding five branches and roughly $144 million in assets. The deal, closing in Q4 2026, will bring Zeal’s footprint to 22 branches and about $1.1 billion in assets...
By Banking Dive
News•Jan 9, 2026
Democrats Ask Apple and Google to Remove X’s Undressing Bot From Their App Stores
Senators Ron Wyden, Ben Ray Luján and Ed Markey wrote to Apple CEO Tim Cook and Google CEO Sundar Pichai urging the removal of X’s AI chatbot Grok, which has been generating non‑consensual deepfake images that undress women and depict...
By The Verge
News•Jan 9, 2026
IBM's AI 'Bob' Could Be Manipulated to Download and Execute Malware
IBM’s beta AI coding assistant, Bob, is vulnerable to indirect prompt injection, allowing attackers to embed hidden commands in emails or calendar entries. Researchers at Prompt Armor demonstrated that the tool can be tricked into downloading and executing arbitrary shell...
By TechRadar
News•Jan 9, 2026
GRIm Score Predicts Nivolumab Efficacy in Melanoma
A recent multicenter trial found that the Glasgow Prognostic and Immune (GRIm) score reliably predicts response to nivolumab in advanced melanoma. Patients with high GRIm scores achieved a 45% objective response rate, while low‑score patients showed markedly shorter progression‑free survival....
By Bioengineer.org
News•Jan 9, 2026
Novartis to Build Fourth US Radiotherapy Factory in Florida
Novartis announced the construction of its fourth U.S. radiotherapy manufacturing facility, a 35,000‑square‑foot plant in Winter Garden, Florida. The new site is part of the company’s broader $23 billion pledge to expand domestic production across the United States. The factory will...
By Endpoints News
Social•Jan 9, 2026
ROSE Metric: Essential Profitability Gauge for SaaS
Free SaaS Template Fridays 📈 All paths to profitability lead to the ROSE Metric. I created the ROSE Metric years ago, b/c Revenue per FTE can be very misleading. And Rev per FTE is thrown around so much that we've...
By Ben Murray
News•Jan 9, 2026
Tuina Vs. Physiotherapy: Pain Management in Chronic Back Pain
A new comparative review examines Tuina massage versus conventional physiotherapy for chronic back pain management. The analysis cites recent randomized trials indicating both modalities achieve similar reductions in pain intensity for mild-to-moderate cases. Tuina’s manual pressure and meridian focus contrast...
By Bioengineer.org
News•Jan 9, 2026
Smart Leggings Boost Muscle Strength in Seniors
A biotech startup unveiled smart leggings embedded with low‑level electrical stimulation and motion sensors that claim to increase muscle strength in adults over 65. In a 12‑week clinical trial, participants wearing the leggings improved grip strength by 15% and leg...
By Bioengineer.org
News•Jan 9, 2026
2026 FinTech Funding Faces Holiday Hangover
FinTech funding entered 2026 with a post‑holiday lull, recording only six rounds this week. Despite the thin pipeline, three mega‑deals topped $100 million, pushing total capital raised to $734 million. Cyera led the pack with a $400 million Series F that values the AI‑security...
By Fintech Global
News•Jan 9, 2026
BioNTech, UPenn Team up for $50M Seed Fund
BioNTech and the University of Pennsylvania have announced a $50 million seed‑stage venture fund focused on mRNA‑based technologies. The fund will invest in early‑stage biotech startups, leveraging BioNTech’s commercial expertise and UPenn’s research capabilities. By targeting vaccine and therapeutic platforms, the...
By Endpoints News
Social•Jan 9, 2026
AI Landscape Visualized: From ML to Generative Models
Core concepts in Artificial Intelligence — clearly mapped in one visual. From Machine Learning and Deep Learning to NLP, Computer Vision, Reinforcement Learning, Robotics, and Generative Models, this overview highlights how the AI ecosystem fits together and where each discipline...
By Giuliano Liguori
Social•Jan 9, 2026
Chinese Hospital's Blood‑Drawing Robot Hits 94.3% Success
Chinese Hospital Deploys Blood-Drawing #Robot Achieving a 94.3% Success Rate by @Khulood_Almani #Robotics #MachineLearning #ArtificialIntelligence https://t.co/lg80dWYLHD
By Ronald van Loon
News•Jan 9, 2026
Single-Cell Tests Predict Mycobacterial Infection Outcomes
A new study demonstrates that single‑cell transcriptional profiling can accurately predict outcomes of mycobacterial infections, distinguishing patients who will progress to active disease from those who remain latent. Researchers analyzed thousands of individual immune cells from blood samples, identifying distinct...
By Bioengineer.org
Social•Jan 9, 2026
AI-Powered Prosthetic Hand Adapts Through Daily Use
A Smarter Prosthetic: Esper Bionics’ #AI Hand Learns from Everyday Use by @EsperBionics #EmergingTech #Technology #Innovation https://t.co/hvj57gAnDV
By Ronald van Loon
Social•Jan 9, 2026
Exploring Nvidia's Alpamayo, Atlas Bot, and New AI Tools
AND WE'RE BACK... We dive into @nvidia's big Alpamayo AI car platform, Boston Dynamic's new ATLAS bot and way more AI bots. Plus, we take on Claude Code + Ralph Wiggum, OpenAI's new audio device and shout out @fofrAI's very good JSON...
By AI for Humans
Blog•Jan 9, 2026
Why Your Social Media Growth Stalled (And The Algorithm Isn’t The Problem)
The article debunks the myth that social‑media algorithms are solely to blame for stagnant growth, pointing instead to strategic missteps. It outlines 20 common pitfalls—from creating algorithm‑centric content to inconsistent posting and weak community engagement—and offers concrete fixes such as...
By BloggingWizard
Social•Jan 9, 2026
Zero‑downtime Migration of 5+ PB From AWS to On‑prem
Jeremy, a 19-year veteran of 37signals, calmly walks through the process moving 5+ petabytes of data and billions of individual files off AWS and onto our own on-prem storage setup without a second of downtime. The how, the time, and the...
By Jason Fried
Social•Jan 9, 2026
CHIP Clones Raise Cardiovascular Risk in Cancer Survivors
More evidence that blood stem cell clones (CHIP), common with increasing age, increase the risk of cardiovascular events, from people treated with cancer https://t.co/56YDjxshjg https://t.co/kdUksoCFmI
By Eric Topol
Social•Jan 9, 2026
Red Blood Cells Drive Vascular Damage in Long‑Term Type 2 Diabetes
Implicating red cells as an underpinning of the vascular damage seen with long duration Type 2 diabetes https://t.co/FzvmreCtn7 https://t.co/MdgpHmpRvo
By Eric Topol
Social•Jan 9, 2026
Anthropic's Provider Lockdown Seen As Customer Hostility
I love the models Anthropic are offering, but I seriously hope it's a mistake that they're blocking alternative harness providers, like @opencode, from working with their subscriptions. Seems very customer hostile. https://t.co/afxEQ0XTFb
By David Heinemeier Hansson
Social•Jan 9, 2026
Nominate Under‑35 Biotech Trailblazers for 2026 Award
Do you know an up and coming someone killing it in biotech? If they're under 35 years of age, please nominate them for the 2026 Technology Review 35 Innovators Under 35 Award. (or just email me. address is in bio) https://t.co/90fwj4GjNU
By Antonio Regalado
Social•Jan 9, 2026
Eric Schmidt's Foundation Launches New Observatory System
Former Google CEO Eric Schmidt announced late Wednesday that @schmidtsciences, one of his philanthropies, would build the Eric and Wendy Schmidt Observatory System. https://t.co/MJJA9jqN9O
By Payload